WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004008153) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HOMO SAPIENS PUTATIVE NEUROTRANSMITTER RECEPTOR (PNR)
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/008153    International Application No.:    PCT/EP2003/007092
Publication Date: 22.01.2004 International Filing Date: 03.07.2003
IPC:
G01N 33/566 (2006.01), G01N 33/74 (2006.01), G01N 33/94 (2006.01)
Applicants: BAYER HEALTHCARE AG [DE/DE]; 51368 Leverkusen (DE) (For All Designated States Except US).
GOLZ, Stefan [DE/DE]; (DE) (For US Only).
BRÜGGEMEIER, Ulf [DE/DE]; (DE) (For US Only).
GEERTS, Andreas [DE/DE]; (DE) (For US Only)
Inventors: GOLZ, Stefan; (DE).
BRÜGGEMEIER, Ulf; (DE).
GEERTS, Andreas; (DE)
Common
Representative:
BAYER HEALTHCARE AG; Law and Patents, Patents and Licensing, 51368 Leverkusen (DE)
Priority Data:
02015619.6 16.07.2002 EP
Title (EN) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HOMO SAPIENS PUTATIVE NEUROTRANSMITTER RECEPTOR (PNR)
(FR) DIAGNOSTIQUE ET THERAPIE DES MALADIES ASSOCIEES AU RECEPTEUR PRESUME DE NEUROTRANSMETTEURS CHEZ L'HUMAIN (PNR)
Abstract: front page image
(EN)The invention provides a human PNR which is associated with the cardiovascular diseases, cns disorders, hematological diseases and genito-urinary diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular diseases, cns disorders, hematological diseases and genito-urinary diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of PNR as well as pharmaceutical compositions comprising such compounds.
(FR)L'invention concerne un PNR humain, associé aux maladies cardio-vasculaires, aux troubles du SNC, aux maladies hématologiques ou encore génito-urinaires. L'invention concerne aussi des dosages destinés à l'identification de composés utiles dans le traitement de maladies cardio-vasculaires, de troubles du SNC, de maladies hématologiques ou encore génito-urinaires. Elle concerne également des composés qui se lient et/ou activent ou inhibent l'activité de PNR ainsi que des compositions pharmaceutiques comprenant ces composés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)